BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6125095)

  • 1. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
    Meier J
    Am Heart J; 1982 Aug; 104(2 Pt 2):364-73. PubMed ID: 6125095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
    Meier J
    Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U
    Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs.
    McDevitt DG
    Eur Heart J; 1987 Dec; 8 Suppl M():9-14. PubMed ID: 2897304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.
    Meier J
    Cardiology; 1979; 64 Suppl 1():1-13. PubMed ID: 42483
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-adrenergic blockers. Choosing among them.
    Vlietstra RE; McGoon MD
    Postgrad Med; 1984 Sep; 76(3):71-3, 76-7, 80. PubMed ID: 6147832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A toxicological review of beta-adrenergic blockers.
    Jackson CD; Fishbein L
    Fundam Appl Toxicol; 1986 Apr; 6(3):395-422. PubMed ID: 2870945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.
    Trap-Jensen J; Carlsen JE; Hartling OJ; Svendsen TL; Tangø M; Christensen NJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):391S-395S. PubMed ID: 6125191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absorption of beta-adrenoceptor antagonists in rat in-situ small intestine; the effect of lipophilicity.
    Taylor DC; Pownall R; Burke W
    J Pharm Pharmacol; 1985 Apr; 37(4):280-3. PubMed ID: 2860233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interindividual pharmacokinetic and pharmacodynamic variability of different beta blockers.
    Dayer P; Mérier G; Perrenoud JJ; Marmy A; Leemann T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S20-4. PubMed ID: 2439813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration.
    Wang W; Sasaki H; Chien DS; Lee VH
    Curr Eye Res; 1991 Jun; 10(6):571-9. PubMed ID: 1680041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.